Archean plans debt for Rs 1,000-1,100 crore chip capex
Key highlights
- Archean has already invested Rs 462.8 crore in its Odisha semiconductor project.
- Archean expects another Rs 1,000 crore to Rs 1,100 crore of semiconductor investment across FY28 and FY29.
- Management said a large part of the additional semiconductor spending will be funded through balance-sheet debt.
- Archean said Odisha project construction has started and indicated an end-to-end timeline of about 24 months.
powered by IRIS

Archean Chemical plans to fund most of an additional Rs 1,000 crore to Rs 1,100 crore investment in its Odisha semiconductor project with balance-sheet debt over FY28 and FY29, after investing Rs 462.8 crore already. Management said the planned outlay covers construction, operating ramp-up and working-capital requirements as volumes build.
Know Archean Chemical Industries inside out
Results, valuation, peers and who's buying, in one view.
How will Archean finance its semiconductor project?
Archean will fund a large part of the additional Rs 1,000 crore to Rs 1,100 crore semiconductor investment through debt on its balance sheet in the near term. Management described debt as the main funding source for the planned spending beyond the Rs 462.8 crore already invested, while saying the final debt level will depend on its internal projections for the chemicals business.
The Rs 1,000 crore to Rs 1,100 crore plan is not only a construction budget. Management said it also includes funding to establish operations as the project ramps up volumes, including the resulting pressure on working capital. This means the company expects cash needs to continue into the operating build-up rather than end when plant construction is completed.
Management said the semiconductor project requires about US$240 million of total capital and that a little less than half would come under the FSA and ISM framework referred to on the call. Archean would invest the remainder. The company did not disclose how much of the Rs 462.8 crore already invested was covered by that framework or provide a final split between debt and any other source within the additional investment range.
When will Archean deploy the semiconductor investment?
Archean confirmed that the planned Rs 1,000 crore to Rs 1,100 crore investment and associated borrowing would be spread over the next two years, FY28 and FY29. Construction has started at the Odisha site, and management had earlier indicated an end-to-end construction period of about 24 months.
The additional plan is more than twice the Rs 462.8 crore already invested. Management said semiconductor projects have high-cost capital items and a front-loaded cash-flow curve, but it did not provide an annual capex, debt-drawdown or repayment schedule for FY28 and FY29.
Archean has not yet disclosed interim construction milestones for the approximately 24-month Odisha project. Management said it would aim to provide greater visibility after further work, following pre-construction steps including FSA approval, engineering, procurement and construction work, and the start of construction. Investors therefore have a two-year funding window but no quarterly deployment timetable.
Got a follow-up? Ask IRIS
How does semiconductor funding differ from chemicals capex?
Archean said core chemicals capital expenditure, excluding the flame-retardant project, should remain within its depreciation curve and be funded from operational accruals. Management said there is front-end spending in the current year for debottlenecking, but distinguished that spending from the substantial new debt planned for the semiconductor project.
Management said it expects to be at “0.6 to 0.7 debt” over a three-year window for the core business, without defining the ratio on the call. The stated distinction is that the semiconductor project requires financing for capital equipment and ramp-up working capital, while ordinary chemicals expenditure is intended to be covered by cash generated through operations.
The flame-retardant project remains an exception in the chemicals capital-spending discussion. Management said phase one of bromine expansion, focused on existing derivatives, captive derivative demand and merchant volumes, should finish by the end of the financial year. It then plans to work on flame retardants and the next bromine expansion step, with possible timing between FY27-FY28 and FY28-FY29, but gave no capex amount or financing mix.
Chemicals execution is also relevant because management said its internal projections for that business will affect both debt levels and repayment timing. In bromine derivatives, first-half revenue was about Rs 66 crore, up about 57% year on year, while finished-goods production in the latest quarter was 2,115 tonnes, close to 40% capacity utilisation. Management expects operating rates to rise over the next couple of quarters, but did not quantify any resulting contribution to semiconductor debt repayment.
What remains undecided on Archean’s debt plan?
Archean has not finalised the financing instrument for the semiconductor project or decided whether borrowings will be denominated in Indian rupees or foreign currency. Management said its team was still working on securing the financing and that it would report or share the details when a specific instrument is selected.
The company also did not disclose an interest rate, lender, maturity profile, repayment schedule or annual borrowing amount within the Rs 1,000 crore to Rs 1,100 crore range. Management said the chemicals business ramp-up would influence the specific level of debt and when repayment should occur, but those internal projections were not shared on the call.
The funding plan comes while Archean is managing other operating and capital priorities. Management said logistics costs had risen by about 15% to 30% because of route changes alone and expected that impact to be largely mitigated over the coming two quarters, assuming no further route changes. It also said the first phase of bromine expansion would be completed by the end of the financial year before work advances on flame retardants and further bromine capacity.
Conclusion
Archean has made a clear financing distinction between its businesses: management expects most ordinary chemicals capex to be funded by operating accruals, while the Odisha semiconductor project will require substantial balance-sheet debt. The Rs 1,000 crore to Rs 1,100 crore additional investment, following Rs 462.8 crore already deployed, includes construction as well as operating and working-capital needs during the ramp-up.
The next disclosures to watch are the debt instrument, currency, borrowing schedule and construction milestones for the Odisha project’s approximately 24-month timeline. Management also plans to complete phase one of bromine expansion by the end of the financial year before progressing flame retardants and further bromine expansion, which could shape the broader capital-allocation position across FY27-FY28 and FY28-FY29.


